Agenus Inc., an immune-oncology company, has appointed José Iglesias, M.D. as Chief Medical Affairs Officer.

Debiopharm has launched the IDEAL Japan initiative, a new program designed to provide financial support to Japanese academic ...

Thermo Fisher Scientific Inc. has opened its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in ...

Halozyme Therapeutics has acquired Elektrofi, a biopharmaceutical company with a proprietary ultra-high concentration ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

BioDuro has launched a new Business Unit dedicated to advancing peptide drug discovery and development for its global biopharma partners.

Tyruko will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. Polpharma Biologics S.A., operating under the Rezon Bio brand and ...

Merus N.V. and Halozyme Therapeutics Inc. have entered into a global non-exclusive collaboration and license agreement.

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...